5-55232560-G-C

Variant summary

Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1

The NM_021147.5(CCNO):​c.382-14C>G variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0799 in 1,612,396 control chromosomes in the GnomAD database, including 5,723 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).

Frequency

Genomes: 𝑓 0.065 ( 389 hom., cov: 33)
Exomes 𝑓: 0.082 ( 5334 hom. )

Consequence

CCNO
NM_021147.5 intron

Scores

2

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:4

Conservation

PhyloP100: 0.780

Publications

6 publications found
Variant links:
Genes affected
CCNO (HGNC:18576): (cyclin O) This gene encodes a member of the cyclin protein family, and the encoded protein is involved in regulation of the cell cycle. Disruption of this gene is associated with primary ciliary dyskinesia-19. Alternative splicing results in multiple transcript variants. This gene, which has a previous symbol of UNG2, was erroneously identified as a uracil DNA glycosylase in PubMed ID: 2001396. A later publication, PubMed ID: 8419333, identified this gene's product as a cyclin protein family member. The UNG2 symbol is also used as a specific protein isoform name for the UNG gene (GeneID 7374), so confusion exists in the scientific literature and in some databases for these two genes. [provided by RefSeq, Jul 2014]
CCNO Gene-Disease associations (from GenCC):
  • primary ciliary dyskinesia 29
    Inheritance: AR Classification: DEFINITIVE, STRONG, MODERATE Submitted by: G2P, Labcorp Genetics (formerly Invitae), PanelApp Australia, ClinGen, Ambry Genetics
  • primary ciliary dyskinesia
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -20 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.69).
BP6
Variant 5-55232560-G-C is Benign according to our data. Variant chr5-55232560-G-C is described in ClinVar as Benign. ClinVar VariationId is 402509.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAd4 highest subpopulation (NFE) allele frequency at 95% confidence interval = 0.0849 is higher than 0.05.

Variant Effect in Transcripts

ACMG analysis was done for transcript: NM_021147.5. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Selected
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
CCNO
NM_021147.5
MANE Select
c.382-14C>G
intron
N/ANP_066970.3
CCNO
NR_125348.1
n.432C>G
non_coding_transcript_exon
Exon 1 of 2
CCNO
NR_125346.2
n.843-14C>G
intron
N/A

Ensembl Transcripts

Selected
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
CCNO
ENST00000282572.5
TSL:1 MANE Select
c.382-14C>G
intron
N/AENSP00000282572.4
CCNO
ENST00000501463.2
TSL:1
n.*362-14C>G
intron
N/AENSP00000422485.1

Frequencies

GnomAD3 genomes
AF:
0.0647
AC:
9852
AN:
152216
Hom.:
389
Cov.:
33
show subpopulations
Gnomad AFR
AF:
0.0325
Gnomad AMI
AF:
0.0945
Gnomad AMR
AF:
0.0659
Gnomad ASJ
AF:
0.104
Gnomad EAS
AF:
0.00154
Gnomad SAS
AF:
0.0532
Gnomad FIN
AF:
0.0651
Gnomad MID
AF:
0.0791
Gnomad NFE
AF:
0.0868
Gnomad OTH
AF:
0.0794
GnomAD2 exomes
AF:
0.0645
AC:
15861
AN:
246032
AF XY:
0.0664
show subpopulations
Gnomad AFR exome
AF:
0.0324
Gnomad AMR exome
AF:
0.0457
Gnomad ASJ exome
AF:
0.0985
Gnomad EAS exome
AF:
0.000381
Gnomad FIN exome
AF:
0.0598
Gnomad NFE exome
AF:
0.0854
Gnomad OTH exome
AF:
0.0781
GnomAD4 exome
AF:
0.0815
AC:
119039
AN:
1460062
Hom.:
5334
Cov.:
32
AF XY:
0.0809
AC XY:
58749
AN XY:
726332
show subpopulations
African (AFR)
AF:
0.0300
AC:
1004
AN:
33464
American (AMR)
AF:
0.0479
AC:
2140
AN:
44702
Ashkenazi Jewish (ASJ)
AF:
0.0980
AC:
2559
AN:
26116
East Asian (EAS)
AF:
0.000227
AC:
9
AN:
39690
South Asian (SAS)
AF:
0.0560
AC:
4831
AN:
86212
European-Finnish (FIN)
AF:
0.0574
AC:
3022
AN:
52638
Middle Eastern (MID)
AF:
0.0970
AC:
551
AN:
5678
European-Non Finnish (NFE)
AF:
0.0899
AC:
99848
AN:
1111232
Other (OTH)
AF:
0.0841
AC:
5075
AN:
60330
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.472
Heterozygous variant carriers
0
5148
10295
15443
20590
25738
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
3632
7264
10896
14528
18160
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.0647
AC:
9853
AN:
152334
Hom.:
389
Cov.:
33
AF XY:
0.0637
AC XY:
4741
AN XY:
74480
show subpopulations
African (AFR)
AF:
0.0326
AC:
1354
AN:
41582
American (AMR)
AF:
0.0658
AC:
1007
AN:
15308
Ashkenazi Jewish (ASJ)
AF:
0.104
AC:
359
AN:
3468
East Asian (EAS)
AF:
0.00154
AC:
8
AN:
5182
South Asian (SAS)
AF:
0.0528
AC:
255
AN:
4828
European-Finnish (FIN)
AF:
0.0651
AC:
691
AN:
10618
Middle Eastern (MID)
AF:
0.0782
AC:
23
AN:
294
European-Non Finnish (NFE)
AF:
0.0868
AC:
5905
AN:
68032
Other (OTH)
AF:
0.0781
AC:
165
AN:
2112
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.502
Heterozygous variant carriers
0
483
966
1448
1931
2414
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
110
220
330
440
550
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.0466
Hom.:
60
Bravo
AF:
0.0638
Asia WGS
AF:
0.0250
AC:
86
AN:
3478

ClinVar

Significance: Benign
Submissions summary: Benign:4
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not provided Benign:2
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided

Nov 10, 2018
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

not specified Benign:1
Mar 29, 2016
Laboratory for Molecular Medicine, Mass General Brigham Personalized Medicine
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

Variant identified in a genome or exome case(s) and assessed due to predicted null impact of the variant or pathogenic assertions in the literature or databases. Disclaimer: This variant has not undergone full assessment. The following are preliminary notes: Frequency

Primary ciliary dyskinesia Benign:1
Feb 03, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.69
CADD
Benign
12
DANN
Benign
0.86
PhyloP100
0.78
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.10
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs72749883; hg19: chr5-54528388; API